PMID- 34649592 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20211022 IS - 1758-5996 (Print) IS - 1758-5996 (Electronic) IS - 1758-5996 (Linking) VI - 13 IP - 1 DP - 2021 Oct 14 TI - CDKN2B-AS1 participates in high glucose-induced apoptosis and fibrosis via NOTCH2 through functioning as a miR-98-5p decoy in human podocytes and renal tubular cells. PG - 107 LID - 10.1186/s13098-021-00725-5 [doi] LID - 107 AB - BACKGROUND: Diabetic nephropathy (DN) is the most common causes of end-stage renal disease. Long non-coding RNA cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) is connected with the development of DN, but the role of CDKN2B-AS1 in DN has not been entirely elucidated. METHODS: Quantitative real-time polymerase chain reaction (qRT-PCR) was carried out to measure CDKN2B-AS1 and miR-98-5p levels. Cell viability, proliferation, and apoptosis were analyzed with 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) or flow cytometry assays. Protein levels were measured by western blotting. The relationship between CDKN2B-AS1 or notch homolog 2 (NOTCH2) and miR-98-5p was verified via dual-luciferase reporter assay. RESULTS: CDKN2B-AS1 and NOTCH2 were upregulated in the serum of DN patients and high glucose-disposed human podocytes (HPCs) and human renal tubular cells (HK-2), whereas miR-98-5p was downregulated. High glucose repressed viability and accelerated apoptosis of HPCs and HK-2 cells. CDKN2B-AS1 knockdown impaired high glucose-induced apoptosis and fibrosis of HPCs and HK-2 cells. Mechanistically, CDKN2B-AS1 sponged miR-98-5p to regulate NOTCH2 expression. Also, CDKN2B-AS1 inhibition-mediated effects on apoptosis and fibrosis of high glucose-disposed HPCs and HK-2 cells were weakened by miR-98-5p inhibitor. Also, NOTCH2 knockdown partly reversed miR-98-5p inhibitor-mediated impacts on apoptosis and fibrosis of high glucose-disposed HPCs and HK-2 cells. CONCLUSION: High glucose-induced CDKN2B-AS1 promoted apoptosis and fibrosis via the TGF-beta1 signaling mediated by the miR-98-5p/NOTCH2 axis in HPCs and HK-2 cells. CI - (c) 2021. The Author(s). FAU - Xiao, Min AU - Xiao M AD - Department of Nephrology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, 107 Wenhua West Road, Jinan, 250012, Shandong, China. FAU - Bai, Shoujun AU - Bai S AD - Department of Nephrology, Qingpu Branch of Zhongshan Hospital Affiliated To Fudan University, Shanghai, 201700, China. FAU - Chen, Jing AU - Chen J AD - School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, 750004, China. FAU - Li, Yaxi AU - Li Y AD - Department of Biomedical Engineering, University of Houston, Houston, TX, 77004, USA. FAU - Zhang, Shu AU - Zhang S AD - Department of Biomedical Engineering, University of Houston, Houston, TX, 77004, USA. FAU - Hu, Zhao AU - Hu Z AD - Department of Nephrology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, 107 Wenhua West Road, Jinan, 250012, Shandong, China. min_xiao_1017@126.com. LA - eng PT - Journal Article DEP - 20211014 PL - England TA - Diabetol Metab Syndr JT - Diabetology & metabolic syndrome JID - 101488958 PMC - PMC8518318 OTO - NOTNLM OT - CDKN2B-AS1 OT - DN OT - NOTCH2 OT - miR-98-5p COIS- The authors declare that they have no competing interests. EDAT- 2021/10/16 06:00 MHDA- 2021/10/16 06:01 PMCR- 2021/10/14 CRDT- 2021/10/15 05:29 PHST- 2021/04/03 00:00 [received] PHST- 2021/09/24 00:00 [accepted] PHST- 2021/10/15 05:29 [entrez] PHST- 2021/10/16 06:00 [pubmed] PHST- 2021/10/16 06:01 [medline] PHST- 2021/10/14 00:00 [pmc-release] AID - 10.1186/s13098-021-00725-5 [pii] AID - 725 [pii] AID - 10.1186/s13098-021-00725-5 [doi] PST - epublish SO - Diabetol Metab Syndr. 2021 Oct 14;13(1):107. doi: 10.1186/s13098-021-00725-5.